The thrombin inhibitor, argatroban, inhibits breast cancer metastasis to bone

ISSN： 1340-6868

Source： Breast Cancer, Vol.20, Iss.3, 2013-07, pp. : 241-246

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

SU11248 inhibits tumor growth and CSF-1R-dependent osteolysis in an experimental breast cancer bone metastasis model

By Murray Lesley Abrams Tinya Long Kelly Ngai Theresa Olson Lisa Hong Weiru Keast Paul Brassard Jacqueline O’Farrell Anne Cherrington Julie Pryer Nancy

Clinical and Experimental Metastasis, Vol. 20, Iss. 8, 2003-12 ,pp. : 757-766

Springer Publishing Company

Access to resources Recommend Favorite

Chemokine (C-X-C motif) receptor 4 RNA interference inhibits bone metastasis in breast cancer

Oncology Letters, Vol. 8, Iss. 1, 2014-01 ,pp. : 77-81

Spandidos Publications

Access to resources Recommend Favorite

DHA is a more potent inhibitor of breast cancer metastasis to bone and related osteolysis than EPA

By Rahman Md Veigas Jyothi Williams Paul Fernandes Gabriel

Breast Cancer Research and Treatment, Vol. 141, Iss. 3, 2013-10 ,pp. : 341-352

Springer Publishing Company

Access to resources Recommend Favorite

Breast cancer bone metastasis and current small therapeutics

By Cicek Muzaffer

Cancer and Metastasis Reviews, Vol. 25, Iss. 4, 2006-12 ,pp. : 635-644

Springer Publishing Company

Access to resources Recommend Favorite

Mouse models of breast cancer metastasis to bone

By Kretschmann Kelsi

Cancer and Metastasis Reviews, Vol. 31, Iss. 3-4, 2012-12 ,pp. : 579-583

Springer Publishing Company

Access to resources Recommend Favorite